Discover

SOLV
Solventum Corporation
87.29
200 x 82.37
100 x 90.00
bid
ask
+
0.88
1.02%
150 @ 04:43 PM
87.29 +0.00 (0.00%)
Ytd10.16%
1y21.57%
86.68
day range
88.23
62.49
52 week range
92.44
Open86.66Prev Close86.41Low86.68High88.23Mkt Cap14.86B
Vol1.06MAvg Vol1.03MEPS8.25P/E10.58Forward P/E12.08
Beta0.70Short Ratio5.26Inst. Own75.92%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0550-d Avg88.41200-d Avg78.071yr Est94.31

SOLV News

Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?
zacks.com
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?

Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combi

Why Solventum (SOLV) is a Top Value Stock for the Long-Term
zacks.com
Why Solventum (SOLV) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Stock Picks From Seeking Alpha's September 2026 New Analysts
seekingalpha.com
Stock Picks From Seeking Alpha's September 2026 New Analysts

Seeking Alpha welcomed 38 new analysts in September 2026. This article showcases their top picks and

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
zacks.com
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks E

Financial Review: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)
defenseworld.net
Financial Review: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)

NeurAxis (NASDAQ: NRXS - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) are both heal

Head to Head Contrast: Solventum (NYSE:SOLV) & Tandem Diabetes Care (NASDAQ:TNDM)
defenseworld.net
Head to Head Contrast: Solventum (NYSE:SOLV) & Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ: TNDM - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) a

Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play
seekingalpha.com
Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play

Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x a

Tidal Investments LLC Sells 7,781 Shares of Solventum Corporation $SOLV
defenseworld.net
Tidal Investments LLC Sells 7,781 Shares of Solventum Corporation $SOLV

Tidal Investments LLC trimmed its position in Solventum Corporation (NYSE: SOLV) by 25.0% in the und

Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
zacks.com
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now

SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though

Here's Why Solventum (SOLV) is a Strong Value Stock
zacks.com
Here's Why Solventum (SOLV) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Why Solventum (SOLV) is a Top Stock for the Long-Term
zacks.com
Why Solventum (SOLV) is a Top Stock for the Long-Term

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus

Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
seekingalpha.com
Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
zacks.com
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?

Solventum (SOLV) reported earnings 30 days ago. What's next for the stock?

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
prnewswire.com
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

EAGAN, Minn., Sept. 2, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management w

Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?
zacks.com
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?

Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 20

Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch
zacks.com
Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Solventum Corporation (NYSE:SOLV) Receives Average Recommendation of “Moderate Buy” from Brokerages
defenseworld.net
Solventum Corporation (NYSE:SOLV) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Solventum Corporation (NYSE: SOLV - Get Free Report) have been given an average recommenda

Why Solventum (SOLV) is a Top Value Stock for the Long-Term
zacks.com
Why Solventum (SOLV) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

SOLV Plans Health Information Systems Business Spinoff to Drive Growth
zacks.com
SOLV Plans Health Information Systems Business Spinoff to Drive Growth

Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS mo

SOLV Energy Q2 Earnings Call Highlights
marketbeat.com
SOLV Energy Q2 Earnings Call Highlights

SOLV Energy NASDAQ: MWH reported record first-half results for 2026, citing increased new-constructi

benzinga.com
UBS Maintains Buy on Solventum, Raises Price Target to $101

UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target

benzinga.com
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises t

benzinga.com
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101

Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the

benzinga.com
Keybanc Maintains Overweight on Solventum, Raises Price Target to $102

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the pr

benzinga.com
Stifel Maintains Buy on Solventum, Raises Price Target to $100

Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target f

benzinga.com
BTIG Maintains Buy on Solventum, Raises Price Target to $95

BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price targe

benzinga.com
Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optim

Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Informatio

benzinga.com
Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B Estimate

Solventum (NYSE:SOLV) reported quarterly earnings of $2.55 per share which beat the analyst consensu

benzinga.com
BMO Capital Initiates Coverage On Solventum with Market Perform Rating, Announces Price Target of $8

BMO Capital initiates coverage on Solventum (NYSE:SOLV) with a Market Perform rating and announces

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

This KB Home Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
benzinga.com
This KB Home Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrade

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

This T-Mobile Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
benzinga.com
This T-Mobile Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

Alphabet, Exact Sciences, And Regeneron Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 17-Nov. 21): Are the Others in Your Portfolio?
benzinga.com
Alphabet, Exact Sciences, And Regeneron Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 17-No

Discover last week's top 10 large-cap stock gainers, why they rallied, and what catalysts drove

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
benzinga.com
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?

U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Re

benzinga.com
Earnings Scheduled For February 27, 2025

finance.yahoo.com
Swarmer, Inc (SWMR) Stock Price, News, Quote & History - Yahoo Finance

At close: October 9 at 4:00:00 PM EDT ...

finance.yahoo.com
Xanadu Quantum Technologies Limited (XNDU)

As of 1:30:04 PM EDT. Market Open. What are the terms of XNDU COO Rafal Janik's share plan? What's b

au.investing.com
SOLV Energy Inc (MWH)

The technical indicators for SOLV Energy are in a Strong Sell position based on daily analysis, with

finanznachrichten.de
SENTIA ASA

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten

Ripple Becoming ‘Major Competitor’ to Wall Street — but Where Does XRP Fit?
ccn.com
Ripple Becoming ‘Major Competitor’ to Wall Street — but Where Does XRP Fit?

Ripple’s expansion into Wall Street financing is putting a familiar concern for XRP holders back int

fidelity.co.uk
Solventum Corp (SOLV)

In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that

marketwatch.com
Solventum Corp. stock rises Friday, outperforms market

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insi